Takaaki Hirotsu
Founder & Chief Executive Officer, Hirotsu Bio Science Inc. · Japan
Takaaki Hirotsu is the CEO of Hirotsu Bio Science Inc.. Hirotsu is based in Japan.
Takaaki Hirotsu is a researcher who invented the N-NOSE cancer screening technology using nematode worms while an assistant professor. He founded Hirotsu Bio Science in 2016 to commercialize early cancer detection, transitioning from university faculty to lead the venture company.
Recent developments
AI summary of recent coverageRecent coverage has focused on Hirotsu Bio Science's development and commercialization of a cancer screening test that uses microscopic nematode worms to detect tumors, particularly for pancreatic cancer detection. Headlines chronicle the company's progression from early research into practical application, including the launch of its N-NOSE® plus Pancreas test and its availability in Japanese clinics, though some scientific scrutiny has emerged regarding the validity of worm-based cancer screening approaches.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Citizenship
- Japan
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Takaaki Hirotsu, it will appear here — and tie into the news timeline.
Takaaki Hirotsu: FAQ
- Who is Takaaki Hirotsu?
- Takaaki Hirotsu is the Founder & Chief Executive Officer of Hirotsu Bio Science Inc., based in Japan.
- What company does Takaaki Hirotsu lead?
- Takaaki Hirotsu is CEO of Hirotsu Bio Science Inc..